ViiV Healthcare announces promising results from LATITUDE phase III trial, showing long-acting HIV treatment Cabenuva's superiority over daily oral therapy...
GSK plc has completed the acquisition of Aiolos Bio, expanding its respiratory biologics portfolio with AIO-001, a potential treatment for asthma patients with low T2 inflammation. The acquisition includes an upfront payment of $1 billion and milestone payments...
GSK plc has received Fast Track designation from the FDA for bepirovirsen, an investigational drug for chronic hepatitis B treatment. This designation highlights the need for effective medications to address this serious condition...
GSK plc's application to extend its RSV vaccine indication to adults aged 50-59 at risk has been accepted by the FDA for priority review. If approved, it would be the first vaccine for this population. The application is supported by positive phase III trial results...
GSK has reached a confidential settlement with David Browne, resolving a California state court case. The company will continue to defend itself in other Zantac cases...
ViiV Healthcare announces promising results from LATITUDE phase III trial, showing long-acting HIV treatment Cabenuva's superiority over daily oral therapy...
GSK plc has completed the acquisition of Aiolos Bio, expanding its respiratory biologics portfolio with AIO-001, a potential treatment for asthma patients with low T2 inflammation. The acquisition includes an upfront payment of $1 billion and milestone payments...
GSK plc has received Fast Track designation from the FDA for bepirovirsen, an investigational drug for chronic hepatitis B treatment. This designation highlights the need for effective medications to address this serious condition...
GSK plc's application to extend its RSV vaccine indication to adults aged 50-59 at risk has been accepted by the FDA for priority review. If approved, it would be the first vaccine for this population. The application is supported by positive phase III trial results...
GSK has reached a confidential settlement with David Browne, resolving a California state court case. The company will continue to defend itself in other Zantac cases...
